Sleeping beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumors

Bobbi R Tschida, Nuri A Temiz, Timothy P. Kuka, Lindsey A. Lee, Jesse D. Riordan, Carlos A. Tierrablanca, Robert Hullsiek, Sandra Wagner, Wendy A. Hudson, Michael A Linden, Khalid Amin, Pauline J Beckmann, Rachel A. Heuer, Aaron L Sarver, Ju Dong Yang, Lewis R. Roberts, Joseph H. Nadeau, Adam J. Dupuy, Vincent W. Keng, David A Largaespada

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Hepatic steatosis is a strong risk factor for the development of hepatocellular carcinoma (HCC), yet little is known about the molecular pathology associated with this factor. In this study, we performed a forward genetic screen using Sleeping Beauty (SB) transposon insertional mutagenesis in mice treated to induce hepatic steatosis and compared the results to human HCC data. In humans, we determined that steatosis increased the proportion of female HCC patients, a pattern also reflected in mice. Our genetic screen identified 203 candidate steatosis-associated HCC genes, many of which are altered in human HCC and are members of established HCC-driving signaling pathways. The protein kinase A/cyclic AMP signaling pathway was altered frequently in mouse and human steatosis-associated HCC. We found that activated PKA expression drove steatosis-specific liver tumorigenesis in a mouse model. Another candidate HCC driver, the N-acetyltransferase NAT10, which we found to be overexpressed in human steatosis–associated HCC and associated with decreased survival in human HCC, also drove liver tumorigenesis in a steatotic mouse model. This study identifies genes and pathways promoting HCC that may represent novel targets for prevention and treatment in the context of hepatic steatosis, an area of rapidly growing clinical significance.

Original languageEnglish (US)
Pages (from-to)6576-6588
Number of pages13
JournalCancer Research
Volume77
Issue number23
DOIs
StatePublished - Dec 1 2017

Fingerprint

Beauty
Insertional Mutagenesis
Hepatocellular Carcinoma
Liver
Neoplasms
Carcinogenesis
Acetyltransferases
Molecular Pathology
Fatty Liver
Cyclic AMP-Dependent Protein Kinases
Cyclic AMP
Genes

Cite this

Sleeping beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumors. / Tschida, Bobbi R; Temiz, Nuri A; Kuka, Timothy P.; Lee, Lindsey A.; Riordan, Jesse D.; Tierrablanca, Carlos A.; Hullsiek, Robert; Wagner, Sandra; Hudson, Wendy A.; Linden, Michael A; Amin, Khalid; Beckmann, Pauline J; Heuer, Rachel A.; Sarver, Aaron L; Yang, Ju Dong; Roberts, Lewis R.; Nadeau, Joseph H.; Dupuy, Adam J.; Keng, Vincent W.; Largaespada, David A.

In: Cancer Research, Vol. 77, No. 23, 01.12.2017, p. 6576-6588.

Research output: Contribution to journalArticle

Tschida, BR, Temiz, NA, Kuka, TP, Lee, LA, Riordan, JD, Tierrablanca, CA, Hullsiek, R, Wagner, S, Hudson, WA, Linden, MA, Amin, K, Beckmann, PJ, Heuer, RA, Sarver, AL, Yang, JD, Roberts, LR, Nadeau, JH, Dupuy, AJ, Keng, VW & Largaespada, DA 2017, 'Sleeping beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumors', Cancer Research, vol. 77, no. 23, pp. 6576-6588. https://doi.org/10.1158/0008-5472.CAN-17-2281
Tschida, Bobbi R ; Temiz, Nuri A ; Kuka, Timothy P. ; Lee, Lindsey A. ; Riordan, Jesse D. ; Tierrablanca, Carlos A. ; Hullsiek, Robert ; Wagner, Sandra ; Hudson, Wendy A. ; Linden, Michael A ; Amin, Khalid ; Beckmann, Pauline J ; Heuer, Rachel A. ; Sarver, Aaron L ; Yang, Ju Dong ; Roberts, Lewis R. ; Nadeau, Joseph H. ; Dupuy, Adam J. ; Keng, Vincent W. ; Largaespada, David A. / Sleeping beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumors. In: Cancer Research. 2017 ; Vol. 77, No. 23. pp. 6576-6588.
@article{000bc10de1844f66bb49d6ae3cb73860,
title = "Sleeping beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumors",
abstract = "Hepatic steatosis is a strong risk factor for the development of hepatocellular carcinoma (HCC), yet little is known about the molecular pathology associated with this factor. In this study, we performed a forward genetic screen using Sleeping Beauty (SB) transposon insertional mutagenesis in mice treated to induce hepatic steatosis and compared the results to human HCC data. In humans, we determined that steatosis increased the proportion of female HCC patients, a pattern also reflected in mice. Our genetic screen identified 203 candidate steatosis-associated HCC genes, many of which are altered in human HCC and are members of established HCC-driving signaling pathways. The protein kinase A/cyclic AMP signaling pathway was altered frequently in mouse and human steatosis-associated HCC. We found that activated PKA expression drove steatosis-specific liver tumorigenesis in a mouse model. Another candidate HCC driver, the N-acetyltransferase NAT10, which we found to be overexpressed in human steatosis–associated HCC and associated with decreased survival in human HCC, also drove liver tumorigenesis in a steatotic mouse model. This study identifies genes and pathways promoting HCC that may represent novel targets for prevention and treatment in the context of hepatic steatosis, an area of rapidly growing clinical significance.",
author = "Tschida, {Bobbi R} and Temiz, {Nuri A} and Kuka, {Timothy P.} and Lee, {Lindsey A.} and Riordan, {Jesse D.} and Tierrablanca, {Carlos A.} and Robert Hullsiek and Sandra Wagner and Hudson, {Wendy A.} and Linden, {Michael A} and Khalid Amin and Beckmann, {Pauline J} and Heuer, {Rachel A.} and Sarver, {Aaron L} and Yang, {Ju Dong} and Roberts, {Lewis R.} and Nadeau, {Joseph H.} and Dupuy, {Adam J.} and Keng, {Vincent W.} and Largaespada, {David A}",
year = "2017",
month = "12",
day = "1",
doi = "10.1158/0008-5472.CAN-17-2281",
language = "English (US)",
volume = "77",
pages = "6576--6588",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "23",

}

TY - JOUR

T1 - Sleeping beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumors

AU - Tschida, Bobbi R

AU - Temiz, Nuri A

AU - Kuka, Timothy P.

AU - Lee, Lindsey A.

AU - Riordan, Jesse D.

AU - Tierrablanca, Carlos A.

AU - Hullsiek, Robert

AU - Wagner, Sandra

AU - Hudson, Wendy A.

AU - Linden, Michael A

AU - Amin, Khalid

AU - Beckmann, Pauline J

AU - Heuer, Rachel A.

AU - Sarver, Aaron L

AU - Yang, Ju Dong

AU - Roberts, Lewis R.

AU - Nadeau, Joseph H.

AU - Dupuy, Adam J.

AU - Keng, Vincent W.

AU - Largaespada, David A

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Hepatic steatosis is a strong risk factor for the development of hepatocellular carcinoma (HCC), yet little is known about the molecular pathology associated with this factor. In this study, we performed a forward genetic screen using Sleeping Beauty (SB) transposon insertional mutagenesis in mice treated to induce hepatic steatosis and compared the results to human HCC data. In humans, we determined that steatosis increased the proportion of female HCC patients, a pattern also reflected in mice. Our genetic screen identified 203 candidate steatosis-associated HCC genes, many of which are altered in human HCC and are members of established HCC-driving signaling pathways. The protein kinase A/cyclic AMP signaling pathway was altered frequently in mouse and human steatosis-associated HCC. We found that activated PKA expression drove steatosis-specific liver tumorigenesis in a mouse model. Another candidate HCC driver, the N-acetyltransferase NAT10, which we found to be overexpressed in human steatosis–associated HCC and associated with decreased survival in human HCC, also drove liver tumorigenesis in a steatotic mouse model. This study identifies genes and pathways promoting HCC that may represent novel targets for prevention and treatment in the context of hepatic steatosis, an area of rapidly growing clinical significance.

AB - Hepatic steatosis is a strong risk factor for the development of hepatocellular carcinoma (HCC), yet little is known about the molecular pathology associated with this factor. In this study, we performed a forward genetic screen using Sleeping Beauty (SB) transposon insertional mutagenesis in mice treated to induce hepatic steatosis and compared the results to human HCC data. In humans, we determined that steatosis increased the proportion of female HCC patients, a pattern also reflected in mice. Our genetic screen identified 203 candidate steatosis-associated HCC genes, many of which are altered in human HCC and are members of established HCC-driving signaling pathways. The protein kinase A/cyclic AMP signaling pathway was altered frequently in mouse and human steatosis-associated HCC. We found that activated PKA expression drove steatosis-specific liver tumorigenesis in a mouse model. Another candidate HCC driver, the N-acetyltransferase NAT10, which we found to be overexpressed in human steatosis–associated HCC and associated with decreased survival in human HCC, also drove liver tumorigenesis in a steatotic mouse model. This study identifies genes and pathways promoting HCC that may represent novel targets for prevention and treatment in the context of hepatic steatosis, an area of rapidly growing clinical significance.

UR - http://www.scopus.com/inward/record.url?scp=85037694662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037694662&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-17-2281

DO - 10.1158/0008-5472.CAN-17-2281

M3 - Article

C2 - 28993411

AN - SCOPUS:85037694662

VL - 77

SP - 6576

EP - 6588

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 23

ER -